Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric, Observational Study to Evaluate Real World Data of Avelumab in First Line Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma, a SOGUG Study

NCT05700344 is registered in ClinicalTrials.gov with Spanish Oncology Genito-Urinary Group as lead sponsor.

NCT NCT05700344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05700344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric, Observational Study to Evaluate Real World Data of Avelumab in First Line Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma, a SOGUG Study
Lead sponsor
Spanish Oncology Genito-Urinary Group
Phase
Observational
Overall status
Completed
Start date
September 5, 2022
Completion date
November 2, 2023
Enrollment
125 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic urothelial carcinoma